These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Generic Platform for Cellular Screening Against Ubiquitin Ligases. Maculins T; Carter N; Dorval T; Hudson K; Nissink JW; Hay RT; Alwan H Sci Rep; 2016 Jan; 6():18940. PubMed ID: 26743172 [TBL] [Abstract][Full Text] [Related]
5. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases. Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574 [TBL] [Abstract][Full Text] [Related]
6. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. De Cesare V; Johnson C; Barlow V; Hastie J; Knebel A; Trost M Cell Chem Biol; 2018 Sep; 25(9):1117-1127.e4. PubMed ID: 30017913 [TBL] [Abstract][Full Text] [Related]
7. Orchestra for assembly and fate of polyubiquitin chains. Kuhlbrodt K; Mouysset J; Hoppe T Essays Biochem; 2005; 41():1-14. PubMed ID: 16250894 [TBL] [Abstract][Full Text] [Related]
8. Overview of approaches for screening for ubiquitin ligase inhibitors. Sun Y Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387 [TBL] [Abstract][Full Text] [Related]
10. Novel E3 ubiquitin ligases that regulate histone protein levels in the budding yeast Saccharomyces cerevisiae. Singh RK; Gonzalez M; Kabbaj MH; Gunjan A PLoS One; 2012; 7(5):e36295. PubMed ID: 22570702 [TBL] [Abstract][Full Text] [Related]
11. Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays. Andrews PS; Schneider S; Yang E; Michaels M; Chen H; Tang J; Emkey R Assay Drug Dev Technol; 2010 Aug; 8(4):471-87. PubMed ID: 20804422 [TBL] [Abstract][Full Text] [Related]
12. A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein-Protein Interaction Inhibitors. Weber E; Rothenaigner I; Brandner S; Hadian K; Schorpp K SLAS Discov; 2017 Mar; 22(3):316-323. PubMed ID: 27909234 [TBL] [Abstract][Full Text] [Related]
13. Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination. DiBello A; Datta AB; Zhang X; Wolberger C J Mol Biol; 2016 Nov; 428(23):4639-4650. PubMed ID: 27678051 [TBL] [Abstract][Full Text] [Related]
14. A patent review of the ubiquitin ligase system: 2015-2018. Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221 [TBL] [Abstract][Full Text] [Related]
16. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. Hoppe T Trends Biochem Sci; 2005 Apr; 30(4):183-7. PubMed ID: 15817394 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors. Wilson BAP; Voeller D; Smith EA; Wamiru A; Goncharova EI; Liu G; Lipkowitz S; O'Keefe BR SLAS Discov; 2021 Aug; 26(7):870-884. PubMed ID: 33882749 [TBL] [Abstract][Full Text] [Related]
18. Enzyme reversal to explore the function of yeast E3 ubiquitin-ligases. MacDonald C; Winistorfer S; Pope RM; Wright ME; Piper RC Traffic; 2017 Jul; 18(7):465-484. PubMed ID: 28382714 [TBL] [Abstract][Full Text] [Related]
19. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1. Eisele F; Wolf DH FEBS Lett; 2008 Dec; 582(30):4143-6. PubMed ID: 19041308 [TBL] [Abstract][Full Text] [Related]
20. E3-ubiquitin ligases and recent progress in osteoimmunology. Asano Y; Matsumoto Y; Wada J; Rottapel R Front Immunol; 2023; 14():1120710. PubMed ID: 36911671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]